Figure 1.
Figure 1. The percent change in SPD from baseline following 4 weekly doses of 100mg/m2 of ocaratuzumab

The percent change in SPD from baseline following 4 weekly doses of 100mg/m2 of ocaratuzumab

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal